DHP Korea Co. Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.035x

DHP Korea Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, DHP Korea Co. Ltd (131030) has a cash flow conversion efficiency ratio of 0.035x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.29 Billion ≈ $3.59 Million USD) by net assets (₩150.47 Billion ≈ $101.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of DHP Korea Co. Ltd (2014–2024)

Cash flow conversion efficiency of DHP Korea Co. Ltd from 2014 to 2024. This chart illustrates how DHP Korea Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 131030 stock price and chart for real-time trading data and today's change.

DHP Korea Co. Ltd Cash Flow Conversion Ratio Explained

DHP Korea Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

DHP Korea Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of DHP Korea Co. Ltd ranked by their cash flow conversion efficiency. Also see market value of DHP Korea Co. Ltd for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
CERENO SCIENTIFIC AB B
F:4A1
0.105x
Nature Holdings Co. Ltd.
KQ:298540
0.027x
Chin Yang Ind
KO:003780
0.034x
American Lithium Corp
V:LI
-0.019x
Gold Hydrogen Ltd
AU:GHY
-0.023x
Introl S.A.
WAR:INL
0.123x
Skolon AB
ST:SKOLON
-2.083x
Sangsangin Co. Ltd
KQ:038540
1.338x

Annual Cash Flow Conversion Efficiency for DHP Korea Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of DHP Korea Co. Ltd from 2014 to 2024. Review 131030 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩143.73 Billion
≈ $97.41 Million
₩8.90 Billion
≈ $6.03 Million
0.062x -33.03%
2023-12-31 ₩134.45 Billion
≈ $91.12 Million
₩12.44 Billion
≈ $8.43 Million
0.093x +462.97%
2022-12-31 ₩124.47 Billion
≈ $84.35 Million
₩2.05 Billion
≈ $1.39 Million
0.016x -70.48%
2021-12-31 ₩127.02 Billion
≈ $86.08 Million
₩7.07 Billion
≈ $4.79 Million
0.056x -62.06%
2020-12-31 ₩118.88 Billion
≈ $80.57 Million
₩17.45 Billion
≈ $11.82 Million
0.147x -6.05%
2019-12-31 ₩107.75 Billion
≈ $73.02 Million
₩16.83 Billion
≈ $11.41 Million
0.156x -1.48%
2018-12-31 ₩94.90 Billion
≈ $64.31 Million
₩15.05 Billion
≈ $10.20 Million
0.159x -25.02%
2017-12-31 ₩86.55 Billion
≈ $58.66 Million
₩18.30 Billion
≈ $12.40 Million
0.211x +32.18%
2016-12-31 ₩75.26 Billion
≈ $51.00 Million
₩12.04 Billion
≈ $8.16 Million
0.160x -5.44%
2015-12-31 ₩65.49 Billion
≈ $44.38 Million
₩11.08 Billion
≈ $7.51 Million
0.169x -25.43%
2014-12-31 ₩56.49 Billion
≈ $38.28 Million
₩12.82 Billion
≈ $8.69 Million
0.227x --

About DHP Korea Co. Ltd

KQ:131030 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$60.01 Million
₩88.56 Billion KRW
Market Cap Rank
#21005 Global
#1204 in Korea
Share Price
₩5790.00
Change (1 day)
+1.76%
52-Week Range
₩4900.00 - ₩19260.00
All Time High
₩19260.00
About

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company… Read more